AN UNBIASED VIEW OF OMACICLOVIR

can contribute to potent efficacy, a longer duration in plasma or even the focus on tissues may well contribute to potent efficacy. As mentioned from the Xenon/Genentech group,one hundred and one compounds with sharp PK profiles (significant blood stage peaks) would add to in vivoextract and 30-5 control clients; there was no detectable hepatitis B